The Impact of Formulation and Process Changes on In Vitro Dissolution and the Bioequivalence of Piroxicam Capsules

Deborah A. Piscitelli Department of Pharmaceutical Sciences, University of Maryland at Baltimore, 20 N. Pine St., Baltimore, Maryland

Sian Bigora Department of Pharmaceutical Sciences, University of Maryland at Baltimore, 20 N. Pine St., Baltimore, Maryland

Cecil Propst Department of Pharmaceutical Sciences, University of Maryland at Baltimore, 20 N. Pine St., Baltimore, Maryland

Sanjay Goskonda Department of Pharmaceutical Sciences, University of Maryland at Baltimore, 20 N. Pine St., Baltimore, Maryland

Paul Schwartz Food and Drug Administration, 1451 Rockville Pike, Rockville, Maryland

Lawrence J. Lesko Food and Drug Administration, 1451 Rockville Pike, Rockville, Maryland

Larry Augsburger Department of Pharmaceutical Sciences, University of Maryland at Baltimore, 20 N. Pine St., Baltimore, Maryland

David Young Department of Pharmaceutical Sciences, University of Maryland at Baltimore, 20 N. Pine St., Baltimore, Maryland

Your download is now in progress and you may close this window